Krystal Biotech (KRYS) Share-based Compensation (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.13% |
| Dec 31, 2025 | 4.65% |
| Sep 30, 2025 | -6.84% |
| Jun 30, 2025 | 4.76% |
| Mar 31, 2025 | 0.91% |
| Dec 31, 2024 | 0.30% |
| Sep 30, 2024 | 1.22% |
| Jun 30, 2024 | 41.48% |
| Mar 31, 2024 | -5.62% |
| Dec 31, 2023 | 18.54% |
| Sep 30, 2023 | -26.64% |
| Jun 30, 2023 | 8.57% |
| Mar 31, 2023 | 9.27% |
| Dec 31, 2022 | 5.44% |
| Sep 30, 2022 | 10.62% |
| Jun 30, 2022 | 27.36% |
| Mar 31, 2022 | 24.98% |
| Dec 31, 2021 | 40.34% |
| Sep 30, 2021 | -12.61% |
| Jun 30, 2021 | 81.37% |
| Mar 31, 2021 | 305.79% |
| Dec 31, 2020 | -57.96% |
| Sep 30, 2020 | 68.03% |
| Jun 30, 2020 | 49.72% |
| Mar 31, 2020 | 66.87% |
| Dec 31, 2019 | 16.19% |
| Sep 30, 2019 | 10.32% |
| Jun 30, 2019 | -19.49% |
| Mar 31, 2019 | 3.64% |
| Dec 31, 2018 | 79.76% |
| Sep 30, 2018 | 52.73% |
| Jun 30, 2018 | 69.23% |
| Mar 31, 2018 | 12.07% |
| Dec 31, 2017 | 7.41% |
| Sep 30, 2017 | 22.73% |
| Jun 30, 2017 | -51.65% |
| Mar 31, 2017 | 250.00% |
| Dec 31, 2016 | 550.00% |